MedTrace Logo

Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor Responders

NCT00677573 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-05-14

No results posted yet for this study

Summary

We proposed to compare outcomes in women with DOR undergoing ART with rec-FSH + u-HMH with those with u-FSH only in GnRH antagonist protocols.

Conditions

Interventions

DRUG

Fostimon

450 IU for 4 days then adjusted

Sponsors & Collaborators

  • Bahceci Women Health Care Center

    collaborator UNKNOWN

  • German Hospital, Istanbul

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-10-31
Completion
2008-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00677573 on ClinicalTrials.gov